427 related articles for article (PubMed ID: 18205213)
1. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis.
Takashima K; Ohashi M; Kitamura Y; Ando K; Nagashima K; Sugihara H; Okuno K; Sairenji T; Hayashi K
J Med Virol; 2008 Mar; 80(3):455-66. PubMed ID: 18205213
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus can infect rabbits by the intranasal or peroral route: an animal model for natural primary EBV infection in humans.
Okuno K; Takashima K; Kanai K; Ohashi M; Hyuga R; Sugihara H; Kuwamoto S; Kato M; Sano H; Sairenji T; Kanzaki S; Hayashi K
J Med Virol; 2010 May; 82(6):977-86. PubMed ID: 20419811
[TBL] [Abstract][Full Text] [Related]
3. Lifelong persistent EBV infection of rabbits with EBER1-positive lymphocyte infiltration and mild sublethal hemophagocytosis.
Kanai K; Takashima K; Okuno K; Kato K; Sano H; Kuwamoto S; Higaki H; Nagata K; Sugihara H; Kato M; Murakami I; Hayashi K
Virus Res; 2010 Oct; 153(1):172-8. PubMed ID: 20691737
[TBL] [Abstract][Full Text] [Related]
4. In vitro Epstein-Barr virus infection model of rabbit lymphocytes from peripheral blood or spleen.
Kanai K; Kato K; Sano H; Nagata K; Okuno K; Kuwamoto S; Higaki H; Sugihara H; Kato M; Murakami I; Hayashi K
Intervirology; 2011; 54(1):17-24. PubMed ID: 20689312
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus in pediatric patients after renal transplantation.
Schwab M; Böswald M; Korn K; Ruder H
Clin Nephrol; 2000 Feb; 53(2):132-9. PubMed ID: 10711415
[TBL] [Abstract][Full Text] [Related]
6. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E
J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
8. EBNA-2 -deleted Epstein-Barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95-8.
Sano H; Nagata K; Kato K; Kanai K; Yamamoto K; Okuno K; Kuwamoto S; Higaki-Mori H; Sugihara H; Kato M; Murakami I; Kanzaki S; Hayashi K
Intervirology; 2013; 56(2):114-21. PubMed ID: 23295915
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
[TBL] [Abstract][Full Text] [Related]
10. Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS.
Hayashi K; Jin Z; Onoda S; Joko H; Teramoto N; Ohara N; Oda W; Tanaka T; Liu YX; Koirala TR; Oka T; Kondo E; Yoshino T; Takahashi K; Akagi T
Am J Pathol; 2003 May; 162(5):1721-36. PubMed ID: 12707056
[TBL] [Abstract][Full Text] [Related]
11. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
12. Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection.
Hara S; Hoshino Y; Naitou T; Nagano K; Iwai M; Suzuki K; Yamamoto K; Nagasaka T; Morishima T; Kimura H
J Clin Virol; 2006 Mar; 35(3):250-6. PubMed ID: 16181807
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach.
Fukayama M; Hayashi Y; Iwasaki Y; Chong J; Ooba T; Takizawa T; Koike M; Mizutani S; Miyaki M; Hirai K
Lab Invest; 1994 Jul; 71(1):73-81. PubMed ID: 8041121
[TBL] [Abstract][Full Text] [Related]
14. An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits.
Hayashi K; Ohara N; Teramoto N; Onoda S; Chen HL; Oka T; Kondo E; Yoshino T; Takahashi K; Yates J; Akagi T
Am J Pathol; 2001 Apr; 158(4):1533-42. PubMed ID: 11290571
[TBL] [Abstract][Full Text] [Related]
15. [Development of slides for Epstein-Barr virus diagnosis by indirect immunofluorescence].
Pérez GR; Taborda MA; Toffi A; Palonsky M; Pagotto M; Gardiol DN; Giri AA
Medicina (B Aires); 2005; 65(4):315-20. PubMed ID: 16193709
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
17. Detection of Epstein-Barr virus-infected mucosal lymphocytes in nasal polyps.
Tao Q; Srivastava G; Dickens P; Ho FC
Am J Pathol; 1996 Oct; 149(4):1111-8. PubMed ID: 8863660
[TBL] [Abstract][Full Text] [Related]
18. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
19. Survey of nonhuman primates for antibodies reactive with Epstein-Barr virus (EBV) antigens and susceptibility of their lymphocytes for immortalization with EBV.
Ishida T; Yamamoto K
J Med Primatol; 1987; 16(6):359-71. PubMed ID: 2828628
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
